Paper745019
Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration.
Reynolds GP and 4 others. J Neural Transm, 1978. Cited by 114 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration. Papers, record 745019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/745019
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphetamines | Major topic |
| Brain | Major topic |
| Parkinson Disease | Major topic |
| Phenethylamines | Major topic |
| Selegiline | Major topic |
| Humans |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 168,908 | Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors. | Arzneimittelforschung | 1975 | https://conductscience.org/library/papers/168908 | PubMed |
| 2 | 7,373,300 | The determination and distribution of 2-phenylethylamine in sheep brain. | J Neurochem | 1980 | https://conductscience.org/library/papers/7373300 | PubMed |
| 3 | 4,748,552 | Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. | J Pharmacol Exp Ther | 1973 | https://conductscience.org/library/papers/4748552 | PubMed |
| 4 | 17,437 | The actions of amphetamine on neurotransmitters: a brief review. | Biol Psychiatry | 1977 | https://conductscience.org/library/papers/17437 | PubMed |
| 5 | 14,161,143 | FORMATION OF BETA-PHENYLETHYLAMINE IN MAMMALIAN TISSUE AND ITS EFFECT ON MOTOR ACTIVITY IN THE MOUSE. | J Pharmacol Exp Ther | 1964 | https://conductscience.org/library/papers/14161143 | PubMed |
| 6 | 728,327 | Deprenyl is metabolized to methamphetamine and amphetamine in man. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/728327 | PubMed |
| 7 | 1,097,600 | Amphetamines in the treatment of Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1975 | https://conductscience.org/library/papers/1097600 | PubMed |
| 8 | 696,465 | Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studies. | Adv Biochem Psychopharmacol | 1978 | https://conductscience.org/library/papers/696465 | PubMed |
| 9 | 1,172,524 | The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil. | J Neural Transm | 1975 | https://conductscience.org/library/papers/1172524 | PubMed |
| 10 | 71,602 | Deprenyl in Parkinson's disease. | Lancet | 1977 | https://conductscience.org/library/papers/71602 | PubMed |
| 11 | 834,248 | Dopamine is a monoamine oxidase B substrate in man. | Nature | 1977 | https://conductscience.org/library/papers/834248 | PubMed |
| 12 | 861,765 | Phenylethylamine: evidence for a direct, postsynaptic dopamine-receptor stimulating action. | Brain Res | 1977 | https://conductscience.org/library/papers/861765 | PubMed |
| 13 | 96,466 | Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'. | Psychopharmacology (Berl) | 1978 | https://conductscience.org/library/papers/96466 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,228,857 | COVID-19 infection and neurodegeneration: Computational evidence for interactions between the SARS-CoV-2 spike protein and monoamine oxidase enzymes. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/35228857 | PubMed |
| 34,935,080 | The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin. | J Neural Transm (Vienna) | 2022 | https://conductscience.org/library/papers/34935080 | PubMed |
| 31,562,557 | Selegiline: a molecule with innovative potential. | J Neural Transm (Vienna) | 2020 | https://conductscience.org/library/papers/31562557 | PubMed |
| 30,386,930 | Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease. | J Neural Transm (Vienna) | 2019 | https://conductscience.org/library/papers/30386930 | PubMed |
| 30,341,696 | Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases. | J Neural Transm (Vienna) | 2018 | https://conductscience.org/library/papers/30341696 | PubMed |
| 29,569,037 | Monoamine oxidase-B inhibitors in the treatment of Parkinson's disease: clinical-pharmacological aspects. | J Neural Transm (Vienna) | 2018 | https://conductscience.org/library/papers/29569037 | PubMed |
| 29,417,334 | Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease. | J Neural Transm (Vienna) | 2018 | https://conductscience.org/library/papers/29417334 | PubMed |
| 29,159,774 | Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects. | Clin Drug Investig | 2018 | https://conductscience.org/library/papers/29159774 | PubMed |
| 27,520,753 | The Role of Metabolites of Antidepressants in the Treatment of Depression. | CNS Drugs | 1997 | https://conductscience.org/library/papers/27520753 | PubMed |
| 25,322,951 | Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease. | CNS Drugs | 2014 | https://conductscience.org/library/papers/25322951 | PubMed |
| 22,936,314 | Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts. | Drug Metab Dispos | 2012 | https://conductscience.org/library/papers/22936314 | PubMed |
| 22,389,809 | Apathy and anhedonia in Parkinson's disease. | ISRN Neurol | 2011 | https://conductscience.org/library/papers/22389809 | PubMed |
| 22,110,357 | MAO-inhibitors in Parkinson's Disease. | Exp Neurobiol | 2011 | https://conductscience.org/library/papers/22110357 | PubMed |
| 20,725,780 | R-deprenyl: pharmacological spectrum of its activity. | Neurochem Res | 2010 | https://conductscience.org/library/papers/20725780 | PubMed |
| 19,396,396 | Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain. | J Neural Transm (Vienna) | 2009 | https://conductscience.org/library/papers/19396396 | PubMed |
| 15,537,168 | In vitro formation of selegiline-N-oxide as a metabolite of selegiline in human, hamster, mouse, rat, guinea-pig, rabbit and dog. | Eur J Drug Metab Pharmacokinet | 2004 | https://conductscience.org/library/papers/15537168 | PubMed |
| 15,339,864 | Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline. | Br J Pharmacol | 2004 | https://conductscience.org/library/papers/15339864 | PubMed |
| 11,159,700 | Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11159700 | PubMed |
| 10,319,194 | Metabolism of monoamine oxidase inhibitors. | Cell Mol Neurobiol | 1999 | https://conductscience.org/library/papers/10319194 | PubMed |
| 9,704,592 | Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain. | Neurochem Res | 1998 | https://conductscience.org/library/papers/9704592 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MAOB | 4,129 | PubTator's text mining | https://conductscience.org/library/genes/4129 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/745019
GET https://conductscience.org/api/papers/v1/745019/cited_by?page=2